Neuroinflammation and Secretase Regulation in Alzheimer’s Disease: From Molecular Cross-Talk to Multi-Target Therapeutics
International Journal of Molecular Sciences · 27.05.2026 · 27 (11) · 4824
DOI: 10.3390/ijms27114824 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.05.2026. Verfasst von Giovanni Luca Cipriano und 6 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid Precursor Protein Secretases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministry of Health, Italy.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β (Aβ) plaque deposition, neurofibrillary tau tangles, synaptic dysfunction, and progressive cognitive decline. AD is increasingly recognized as a condition in which chronic neuroinflammation actively shifts amyloid precursor protein (APP) processing toward the amyloidogenic pathway, driving Aβ production and accumulation rather than merely accompanying amyloid deposition. In this review, we examine the molecular cross-talk between inflammatory signalling and secretase regulation, highlighting how pro-inflammatory mediators promote amyloidogenic processing and contribute to downstream synaptic dysfunction. We discuss the major pathways linking glial activation to aberrant APP cleavage, including STAT3-dependent BACE1 upregulation, immune-mediated modulation of γ-secretase through IFITM3, and activation of the C/EBPβ/δ-secretase axis, which connects inflammatory stress to both amyloid and tau pathology. We further address the contribution of epigenetic mechanisms, particularly microRNA-mediated derepression of BACE1 and suppression of ADAM10, as well as SIRT3-related impairment of Aβ clearance. These interconnected processes establish a feed-forward pathogenic network in which neuroinflammation amplifies secretase imbalance, amyloidogenesis, and synaptic vulnerability. Finally, we discuss emerging multi-target therapeutic strategies aimed at modulating inflammatory signalling, restoring non-amyloidogenic APP processing, and preserving proteostatic and synaptic resilience. Collectively, this framework supports the view that targeting the inflammatory control of secretase activity may represent a biologically relevant strategy for disease modification in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
- Department of Biomedical and Dental Sciences and Morpho-Functional Imaging-BIOMORF, University of Messina, 98125 Messina, Italy.
ORCID-Profile: Giovanni Luca Cipriano, Ivan Anchesi, Ivana Raffaele, Maria Francesca Astorino, Aurelio Minuti, Marco Calabrò, Concetta Crisafulli
Förderung
- Ministero della Salute
- Ministry of Health, Italy
Zitieren
APA
Cipriano, G. L., Anchesi, I., Raffaele, I., Astorino, M. F., Minuti, A., Calabrò, M., & Crisafulli, C. (2026). Neuroinflammation and Secretase Regulation in Alzheimer’s Disease: From Molecular Cross-Talk to Multi-Target Therapeutics. International Journal of Molecular Sciences, 27(11), 4824. https://doi.org/10.3390/ijms27114824
Vancouver
Cipriano GL, Anchesi I, Raffaele I, Astorino MF, Minuti A, Calabrò M, et al. Neuroinflammation and Secretase Regulation in Alzheimer’s Disease: From Molecular Cross-Talk to Multi-Target Therapeutics. International Journal of Molecular Sciences. 2026;27(11):4824. doi:10.3390/ijms27114824
BibTeX
@article{Cipriano2026,
author = {Cipriano, Giovanni Luca and Anchesi, Ivan and Raffaele, Ivana and Astorino, Maria Francesca and Minuti, Aurelio and Calabrò, Marco and Crisafulli, Concetta},
title = {Neuroinflammation and Secretase Regulation in Alzheimer’s Disease: From Molecular Cross-Talk to Multi-Target Therapeutics},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4824},
doi = {10.3390/ijms27114824}
}
EUVIMED